Global Point-of-care Testing (POCT) for Infectious Diseases Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Infectious Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Infectious Diseases market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Infectious Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Infectious Diseases market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, Danaher and BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Infectious Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Point-of-care Testing (POCT) for Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Infectious Diseases from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Infectious Diseases competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Infectious Diseases breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Infectious Diseases market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Infectious Diseases.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Infectious Diseases sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Infectious Diseases market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Point-of-care Testing (POCT) for Infectious Diseases market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Point-of-care Testing (POCT) for Infectious Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Point-of-care Testing (POCT) for Infectious Diseases market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, Danaher and BD, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Point-of-care Testing (POCT) for Infectious Diseases market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Based on Colloidal Gold
- Based on Chemiluminescence
- Based on Fluorescence Immunochromatography
- Other
- Hospital
- lndependent Testing Organization
- Roche
- Abbott
- Siemens Healthineers
- Danaher
- BD
- Assure Tech
- BioMerieux
- Bio-Rad Laboratories
- Wondfo
- Wuhan Easy Diagnosis
- Getein Biotech
- Beijing Hotgen Biotech Co.,ltd.
- Beijing Wantai BioPharm
- Zhejiang Orient Gene Biotech Co.,Ltd.
- Sansure Biotech Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Point-of-care Testing (POCT) for Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Infectious Diseases, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Infectious Diseases from 2018 to 2023.
Chapter 3, the Point-of-care Testing (POCT) for Infectious Diseases competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Infectious Diseases breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Point-of-care Testing (POCT) for Infectious Diseases market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Infectious Diseases.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Infectious Diseases sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Infectious Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Colloidal Gold
1.3.3 Based on Chemiluminescence
1.3.4 Based on Fluorescence Immunochromatography
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.1.4 Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.2.4 Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.4.4 Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Recent Developments/Updates
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.5.4 BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BD Recent Developments/Updates
2.6 Assure Tech
2.6.1 Assure Tech Details
2.6.2 Assure Tech Major Business
2.6.3 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.6.4 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Assure Tech Recent Developments/Updates
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.7.4 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioMerieux Recent Developments/Updates
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Laboratories Recent Developments/Updates
2.9 Wondfo
2.9.1 Wondfo Details
2.9.2 Wondfo Major Business
2.9.3 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.9.4 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Wondfo Recent Developments/Updates
2.10 Wuhan Easy Diagnosis
2.10.1 Wuhan Easy Diagnosis Details
2.10.2 Wuhan Easy Diagnosis Major Business
2.10.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.10.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Easy Diagnosis Recent Developments/Updates
2.11 Getein Biotech
2.11.1 Getein Biotech Details
2.11.2 Getein Biotech Major Business
2.11.3 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.11.4 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Getein Biotech Recent Developments/Updates
2.12 Beijing Hotgen Biotech Co.,ltd.
2.12.1 Beijing Hotgen Biotech Co.,ltd. Details
2.12.2 Beijing Hotgen Biotech Co.,ltd. Major Business
2.12.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.12.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
2.13 Beijing Wantai BioPharm
2.13.1 Beijing Wantai BioPharm Details
2.13.2 Beijing Wantai BioPharm Major Business
2.13.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.13.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing Wantai BioPharm Recent Developments/Updates
2.14 Zhejiang Orient Gene Biotech Co.,Ltd.
2.14.1 Zhejiang Orient Gene Biotech Co.,Ltd. Details
2.14.2 Zhejiang Orient Gene Biotech Co.,Ltd. Major Business
2.14.3 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.14.4 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
2.15 Sansure Biotech Inc.
2.15.1 Sansure Biotech Inc. Details
2.15.2 Sansure Biotech Inc. Major Business
2.15.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.15.4 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sansure Biotech Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Infectious Diseases Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Infectious Diseases Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
12.2 Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
12.3 Point-of-care Testing (POCT) for Infectious Diseases Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Infectious Diseases and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Infectious Diseases
13.3 Point-of-care Testing (POCT) for Infectious Diseases Production Process
13.4 Point-of-care Testing (POCT) for Infectious Diseases Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors
14.3 Point-of-care Testing (POCT) for Infectious Diseases Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Infectious Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Based on Colloidal Gold
1.3.3 Based on Chemiluminescence
1.3.4 Based on Fluorescence Immunochromatography
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (2018-2029)
1.5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.1.4 Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.2.4 Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbott Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.4.4 Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Danaher Recent Developments/Updates
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.5.4 BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BD Recent Developments/Updates
2.6 Assure Tech
2.6.1 Assure Tech Details
2.6.2 Assure Tech Major Business
2.6.3 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.6.4 Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Assure Tech Recent Developments/Updates
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.7.4 BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioMerieux Recent Developments/Updates
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Laboratories Recent Developments/Updates
2.9 Wondfo
2.9.1 Wondfo Details
2.9.2 Wondfo Major Business
2.9.3 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.9.4 Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Wondfo Recent Developments/Updates
2.10 Wuhan Easy Diagnosis
2.10.1 Wuhan Easy Diagnosis Details
2.10.2 Wuhan Easy Diagnosis Major Business
2.10.3 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.10.4 Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Easy Diagnosis Recent Developments/Updates
2.11 Getein Biotech
2.11.1 Getein Biotech Details
2.11.2 Getein Biotech Major Business
2.11.3 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.11.4 Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Getein Biotech Recent Developments/Updates
2.12 Beijing Hotgen Biotech Co.,ltd.
2.12.1 Beijing Hotgen Biotech Co.,ltd. Details
2.12.2 Beijing Hotgen Biotech Co.,ltd. Major Business
2.12.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.12.4 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
2.13 Beijing Wantai BioPharm
2.13.1 Beijing Wantai BioPharm Details
2.13.2 Beijing Wantai BioPharm Major Business
2.13.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.13.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing Wantai BioPharm Recent Developments/Updates
2.14 Zhejiang Orient Gene Biotech Co.,Ltd.
2.14.1 Zhejiang Orient Gene Biotech Co.,Ltd. Details
2.14.2 Zhejiang Orient Gene Biotech Co.,Ltd. Major Business
2.14.3 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.14.4 Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
2.15 Sansure Biotech Inc.
2.15.1 Sansure Biotech Inc. Details
2.15.2 Sansure Biotech Inc. Major Business
2.15.3 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
2.15.4 Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sansure Biotech Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POINT-OF-CARE TESTING (POCT) FOR INFECTIOUS DISEASES BY MANUFACTURER
3.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Manufacturer (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Manufacturer (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2022
3.4.2 Top 6 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer Market Share in 2022
3.5 Point-of-care Testing (POCT) for Infectious Diseases Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Infectious Diseases Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2029)
4.1.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2029)
4.1.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2018-2029)
4.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.5 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
5.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2018-2029)
5.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
6.2 Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2018-2029)
6.3 Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
7.2 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
7.3 North America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
7.3.2 North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
8.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
8.3 Europe Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
8.3.2 Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
10.2 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
10.3 South America Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
10.3.2 South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
12.2 Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
12.3 Point-of-care Testing (POCT) for Infectious Diseases Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Point-of-care Testing (POCT) for Infectious Diseases and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Infectious Diseases
13.3 Point-of-care Testing (POCT) for Infectious Diseases Production Process
13.4 Point-of-care Testing (POCT) for Infectious Diseases Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors
14.3 Point-of-care Testing (POCT) for Infectious Diseases Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 6. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Abbott Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Major Business
Table 10. Abbott Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 11. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Abbott Recent Developments/Updates
Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthineers Major Business
Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Siemens Healthineers Recent Developments/Updates
Table 18. Danaher Basic Information, Manufacturing Base and Competitors
Table 19. Danaher Major Business
Table 20. Danaher Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 21. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Danaher Recent Developments/Updates
Table 23. BD Basic Information, Manufacturing Base and Competitors
Table 24. BD Major Business
Table 25. BD Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 26. BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BD Recent Developments/Updates
Table 28. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 29. Assure Tech Major Business
Table 30. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 31. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Assure Tech Recent Developments/Updates
Table 33. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 34. BioMerieux Major Business
Table 35. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 36. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. BioMerieux Recent Developments/Updates
Table 38. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Rad Laboratories Major Business
Table 40. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 41. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Rad Laboratories Recent Developments/Updates
Table 43. Wondfo Basic Information, Manufacturing Base and Competitors
Table 44. Wondfo Major Business
Table 45. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 46. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Wondfo Recent Developments/Updates
Table 48. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Easy Diagnosis Major Business
Table 50. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 51. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Easy Diagnosis Recent Developments/Updates
Table 53. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Getein Biotech Major Business
Table 55. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 56. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Getein Biotech Recent Developments/Updates
Table 58. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 60. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 61. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 63. Beijing Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 64. Beijing Wantai BioPharm Major Business
Table 65. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 66. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Beijing Wantai BioPharm Recent Developments/Updates
Table 68. Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Zhejiang Orient Gene Biotech Co.,Ltd. Major Business
Table 70. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 71. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
Table 73. Sansure Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Sansure Biotech Inc. Major Business
Table 75. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 76. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sansure Biotech Inc. Recent Developments/Updates
Table 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Point-of-care Testing (POCT) for Infectious Diseases, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Point-of-care Testing (POCT) for Infectious Diseases Production Site of Key Manufacturer
Table 83. Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Type Footprint
Table 84. Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Application Footprint
Table 85. Point-of-care Testing (POCT) for Infectious Diseases New Market Entrants and Barriers to Market Entry
Table 86. Point-of-care Testing (POCT) for Infectious Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Point-of-care Testing (POCT) for Infectious Diseases Raw Material
Table 146. Key Manufacturers of Point-of-care Testing (POCT) for Infectious Diseases Raw Materials
Table 147. Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors
Table 148. Point-of-care Testing (POCT) for Infectious Diseases Typical Customers
Table 1. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 6. Roche Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Abbott Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Major Business
Table 10. Abbott Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 11. Abbott Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Abbott Recent Developments/Updates
Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthineers Major Business
Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Siemens Healthineers Recent Developments/Updates
Table 18. Danaher Basic Information, Manufacturing Base and Competitors
Table 19. Danaher Major Business
Table 20. Danaher Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 21. Danaher Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Danaher Recent Developments/Updates
Table 23. BD Basic Information, Manufacturing Base and Competitors
Table 24. BD Major Business
Table 25. BD Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 26. BD Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BD Recent Developments/Updates
Table 28. Assure Tech Basic Information, Manufacturing Base and Competitors
Table 29. Assure Tech Major Business
Table 30. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 31. Assure Tech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Assure Tech Recent Developments/Updates
Table 33. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 34. BioMerieux Major Business
Table 35. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 36. BioMerieux Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. BioMerieux Recent Developments/Updates
Table 38. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Rad Laboratories Major Business
Table 40. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 41. Bio-Rad Laboratories Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Rad Laboratories Recent Developments/Updates
Table 43. Wondfo Basic Information, Manufacturing Base and Competitors
Table 44. Wondfo Major Business
Table 45. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 46. Wondfo Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Wondfo Recent Developments/Updates
Table 48. Wuhan Easy Diagnosis Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Easy Diagnosis Major Business
Table 50. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 51. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Easy Diagnosis Recent Developments/Updates
Table 53. Getein Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Getein Biotech Major Business
Table 55. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 56. Getein Biotech Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Getein Biotech Recent Developments/Updates
Table 58. Beijing Hotgen Biotech Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Hotgen Biotech Co.,ltd. Major Business
Table 60. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 61. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 63. Beijing Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 64. Beijing Wantai BioPharm Major Business
Table 65. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 66. Beijing Wantai BioPharm Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Beijing Wantai BioPharm Recent Developments/Updates
Table 68. Zhejiang Orient Gene Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Zhejiang Orient Gene Biotech Co.,Ltd. Major Business
Table 70. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 71. Zhejiang Orient Gene Biotech Co.,Ltd. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Zhejiang Orient Gene Biotech Co.,Ltd. Recent Developments/Updates
Table 73. Sansure Biotech Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Sansure Biotech Inc. Major Business
Table 75. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Product and Services
Table 76. Sansure Biotech Inc. Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sansure Biotech Inc. Recent Developments/Updates
Table 78. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Point-of-care Testing (POCT) for Infectious Diseases Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Point-of-care Testing (POCT) for Infectious Diseases, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Point-of-care Testing (POCT) for Infectious Diseases Production Site of Key Manufacturer
Table 83. Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Type Footprint
Table 84. Point-of-care Testing (POCT) for Infectious Diseases Market: Company Product Application Footprint
Table 85. Point-of-care Testing (POCT) for Infectious Diseases New Market Entrants and Barriers to Market Entry
Table 86. Point-of-care Testing (POCT) for Infectious Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Point-of-care Testing (POCT) for Infectious Diseases Raw Material
Table 146. Key Manufacturers of Point-of-care Testing (POCT) for Infectious Diseases Raw Materials
Table 147. Point-of-care Testing (POCT) for Infectious Diseases Typical Distributors
Table 148. Point-of-care Testing (POCT) for Infectious Diseases Typical Customers
LIST OF FIGURES
Figure 1. Point-of-care Testing (POCT) for Infectious Diseases Picture
Figure 2. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Type in 2022
Figure 4. Based on Colloidal Gold Examples
Figure 5. Based on Chemiluminescence Examples
Figure 6. Based on Fluorescence Immunochromatography Examples
Figure 7. Other Examples
Figure 8. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. lndependent Testing Organization Examples
Figure 12. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 54. China Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
Figure 75. Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
Figure 76. Point-of-care Testing (POCT) for Infectious Diseases Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases in 2022
Figure 79. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
Figure 80. Point-of-care Testing (POCT) for Infectious Diseases Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Point-of-care Testing (POCT) for Infectious Diseases Picture
Figure 2. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Type in 2022
Figure 4. Based on Colloidal Gold Examples
Figure 5. Based on Chemiluminescence Examples
Figure 6. Based on Fluorescence Immunochromatography Examples
Figure 7. Other Examples
Figure 8. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. lndependent Testing Organization Examples
Figure 12. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Point-of-care Testing (POCT) for Infectious Diseases by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Point-of-care Testing (POCT) for Infectious Diseases Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Point-of-care Testing (POCT) for Infectious Diseases Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 54. China Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Point-of-care Testing (POCT) for Infectious Diseases Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Point-of-care Testing (POCT) for Infectious Diseases Market Drivers
Figure 75. Point-of-care Testing (POCT) for Infectious Diseases Market Restraints
Figure 76. Point-of-care Testing (POCT) for Infectious Diseases Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Infectious Diseases in 2022
Figure 79. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Infectious Diseases
Figure 80. Point-of-care Testing (POCT) for Infectious Diseases Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
